Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.
February is American Heart Month, a time when people are encouraged to focus on their heart health.Heart disease remains the leading cause of death in the U.S.,